Nicotine pouches raise blood pressure in the short term, and there are good mechanistic reasons to suspect they contribute to sustained hypertension with regular use. Each time you tuck a pouch between your lip and gum, nicotine absorbs through the oral lining and triggers a cascade of nervous-system and hormonal responses that push blood pressure upward. Whether that repeated acute spike translates into a lasting diagnosis of high blood pressure is harder to pin down, partly because nicotine pouches are so new that long-term cardiovascular data specific to them simply do not exist yet. The American Heart Association acknowledged as much in a 2024 policy statement, noting that sales of oral nicotine pouches have surged but that no data are available on their cardiovascular or health risks specifically.
The Immediate Blood Pressure Spike
Nicotine is a potent stimulant of the sympathetic nervous system. When it enters your bloodstream, it binds to receptors on nerve endings and on the adrenal glands, triggering a release of adrenaline and noradrenaline. That flood of stress hormones tightens blood vessels and makes the heart beat faster, which drives blood pressure up within minutes.1PubMed. Nicotine and sympathetic neurotransmission In a controlled study using nicotine replacement therapy, nicotine raised mean blood pressure by about 5 mmHg and heart rate by about 7 beats per minute in subjects breathing room air.2PubMed. Acute cardiovascular and sympathetic effects of nicotine replacement therapy Those numbers sound modest, but they represent a single exposure in a lab setting. In real-world use, someone reaching for a pouch every hour or two is re-triggering that spike repeatedly throughout the day.
Nicotine also stimulates the adrenal glands to release epinephrine, and studies on e-cigarette users have confirmed that catecholamine levels rise with nicotine exposure regardless of whether combustion products are present. Elevated epinephrine is directly associated with high blood pressure and, over time, can contribute to the kind of arterial damage that makes hypertension worse.3Tobacco Induced Diseases. Catecholamine levels with use of electronic and combustible cigarettes One review estimated that nicotine can increase plasma adrenaline up to two-and-a-half-fold, heightening the hemodynamic load on the heart and vessels.4Quality in Sport. The Effect of Different Nicotine Delivery Systems on Cardiovascular Health and Hemodynamic Load: A Literature Review
How Much Nicotine Are You Actually Getting?
Nicotine pouches come in a wide range of strengths, and the dose you absorb matters enormously for the blood pressure effect. Low-strength pouches (around 2 mg) deliver significantly less peak nicotine than a cigarette, and the nicotine arrives more slowly, peaking somewhere between 20 and 65 minutes after you place the pouch, compared to 5 to 8 minutes for a cigarette.5PubMed Central. Nicotine pouch pharmacokinetics compared to smoked tobacco: A systematic review and meta-analysis That slower delivery means the blood pressure spike is more gradual and likely less intense than what a cigarette produces at equivalent doses.
But that reassurance evaporates at the higher end of the market. A 4 mg pouch reaches roughly 70% of the peak nicotine concentration of a cigarette. And high-strength pouches marketed in some countries go far beyond that. A study testing 30 mg nicotine pouches found that they delivered nearly double the peak blood nicotine concentration of a cigarette and also raised heart rate by about 25 beats per minute, comparable to the cigarette’s 27 beats per minute increase.6PubMed Central. Small pouches, but high nicotine doses-nicotine delivery and acute effects after use of tobacco-free nicotine pouches In other words, a high-dose pouch can push as much or more nicotine into your system as smoking, and the cardiovascular response scales accordingly.
The pH of the pouch also plays a role. Nicotine exists in two forms: a charged form that absorbs slowly through the mouth’s lining, and a free-base form that crosses membranes much faster. Manufacturers sometimes add alkaline buffering agents to shift the pH upward, increasing the proportion of free-base nicotine. A randomized crossover trial confirmed that the cardiovascular effects of smokeless tobacco, including increases in heart rate and blood pressure, tracked closely with the percentage of free-base nicotine in the product.7PubMed. The pH of Smokeless Tobacco Determines Nicotine Buccal Absorption: Results of a Randomized Crossover Trial Two pouches labeled with the same milligram dose can produce different cardiovascular responses depending on their pH.
Damage to Blood Vessels Over Time
The concern with nicotine pouches goes beyond the moment-to-moment blood pressure bump. Nicotine, independent of tobacco smoke, appears to damage the lining of blood vessels in ways that could make hypertension more likely or more dangerous over time. A review in the European Heart Journal described nicotine as a direct cardiovascular toxin regardless of how it is delivered. It reduces the ability of arteries to relax, increases arterial stiffness, and depletes nitric oxide, a molecule your blood vessels need to stay flexible and healthy. These effects have been observed in users of e-cigarettes and nicotine pouches, not just smokers.8European Heart Journal. Nicotine and the cardiovascular system: unmasking a global public health threat
At the molecular level, nicotine triggers oxidative stress by activating enzymes that produce reactive oxygen species. It also disrupts mitochondrial function in endothelial cells and activates inflammatory pathways that further degrade the vessel lining.9PubMed. Nicotine-associated cardiovascular dysfunction: From pharmacological insights to emerging therapeutic interventions Over time, stiff, inflamed arteries resist blood flow more, which is one of the primary mechanisms behind sustained high blood pressure. A narrative review of snus and nicotine pouches identified these nicotine-mediated pathways, including sympathetic activation, endothelial dysfunction, and increased arterial stiffness, as the most likely route through which oral nicotine products affect cardiovascular health.10PubMed. Snus, nicotine pouches and cardiovascular disease: Evidence, mechanisms, and the challenge of novel nicotine products
A Swedish study comparing chronic snus users to non-users offered a concrete illustration. The snus users had significantly stiffer arteries, measured by pulse wave velocity and augmentation index, even though their resting blood pressure readings were essentially identical to those of controls. Their blood vessels also responded less well to a drug that donates nitric oxide directly to smooth muscle, suggesting the damage extended beyond the vessel lining into the muscle layer itself.11PLOS ONE. Chronic snus use in healthy males alters endothelial function and increases arterial stiffness This is a subtle but important finding: you can have “normal” blood pressure at a single clinic visit while harboring vascular changes that predispose you to hypertension down the road.
What the Long-Term Data Actually Show
Because nicotine pouches have only been widely sold for a few years, there are no long-term epidemiological studies tracking hypertension rates specifically in pouch users. The closest proxy comes from decades of research on Swedish snus, which also delivers nicotine through the oral mucosa without combustion. A prospective study following Swedish men found that snuff users had a roughly 40% higher risk of developing high blood pressure compared to non-users, after adjusting for other risk factors.12PubMed. Risk of hypertension amongst Swedish male snuff users: a prospective study
How well does snus data translate to nicotine pouches? Reasonably well for the nicotine component, since both products deliver nicotine buccally. The key difference is that snus contains tobacco leaf and therefore trace levels of tobacco-specific nitrosamines, while nicotine pouches use synthetic or extracted nicotine with no tobacco plant material. For blood pressure specifically, that distinction probably matters less than it does for cancer risk. The mechanistic pathways linking nicotine to hypertension, from sympathetic activation to endothelial dysfunction to hormonal shifts, operate through nicotine itself rather than through combustion byproducts or nitrosamines. The evidence increasingly suggests that nicotine on its own is the cardiovascular culprit.
How Nicotine Tilts Your Hormonal Blood Pressure Controls
Your body regulates blood pressure through a hormonal system involving an enzyme called ACE, a hormone called angiotensin II, and a set of receptors that either constrict or relax blood vessels. Nicotine pushes this system out of balance. It upregulates the arm that constricts vessels and raises blood pressure while simultaneously suppressing the counterbalancing arm that normally keeps things in check.13PubMed Central. Nicotine and the renin-angiotensin system
Animal research has shown this effect in striking detail. Mice exposed to nicotine vapor for four weeks developed significantly higher mean arterial blood pressure, especially during their active cycle, when pressure climbed to about 124 mmHg compared to 107 mmHg in control animals. The mechanism appeared to involve nicotine suppressing a protective enzyme in the brain’s hypothalamus, a region involved in central regulation of cardiovascular function, as well as in the heart and lungs.14PubMed Central. Nicotine Downregulates the Compensatory Angiotensin-Converting Enzyme 2/Angiotensin Type 2 Receptor of the Renin–Angiotensin System This is relevant to pouch users because the imbalance in this hormonal system is driven by nicotine exposure, not by smoke or tobacco constituents. Any chronic source of nicotine could theoretically produce the same shift.
Does Your Body Get Used to It?
People who use nicotine regularly do develop tolerance to some of its effects, which raises a reasonable question: does the blood pressure spike wear off with habitual use? The answer is mixed. A study comparing smokers and non-smokers found that both groups experienced similar increases in mean arterial pressure and heart rate when given nicotine. Where they differed was in other organ responses: non-smokers showed a significant drop in kidney blood flow and filtration, while smokers’ kidneys were unaffected, suggesting organ-level tolerance.15PubMed. Contrasting renal effects of nicotine in smokers and non-smokers The researchers specifically noted that systemic cardiovascular responses to nicotine, the blood pressure and heart rate increases, persisted despite chronic exposure.
Tolerance clearly develops to nicotine’s subjective and side effects. In a study comparing smokers and non-smokers wearing nicotine patches, the smokers felt nothing from a dose that made seven of eight non-smokers drop out due to nausea and vomiting.16PubMed. Sensitivity and tolerance to nicotine in smokers and nonsmokers But feeling fine is not the same as being fine. The cardiovascular system does not appear to fully habituate to nicotine’s pressure-raising effects the way the gut and brain do to its nauseating effects. You can stop noticing the buzz long before your arteries stop paying the price.
What Happens to Blood Pressure When You Quit
A Swedish cohort study tracked cardiovascular and metabolic changes over 12 weeks in people who stopped using tobacco or nicotine pouches. The results were somewhat counterintuitive. Heart rate dropped by an average of nearly 6 beats per minute in the first week and remained lower through the seventh week, consistent with what you’d expect when sympathetic stimulation is removed. But systolic blood pressure actually increased by an average of about 4 mmHg over the 12-week period, beginning around the fifth week. Diastolic pressure dipped slightly in the first week and then returned to baseline.17PubMed Central. Cardiovascular and metabolic changes following 12 weeks of tobacco and nicotine pouch cessation: a Swedish cohort study
The likely explanation for the systolic rise is weight gain. Participants in that study gained an average of about 1.8 kg over 12 weeks, and weight gain is a well-established driver of increased blood pressure. Nicotine suppresses appetite and raises metabolic rate, so removing it leads to weight gain that can temporarily offset the cardiovascular benefits of quitting. This does not mean quitting is bad for your blood pressure in the long run. It means the short-term picture is complicated, and the trajectory over months to years is what matters for cardiovascular health. The drop in heart rate, reflecting reduced sympathetic drive, is the more telling early signal.
If You Already Have High Blood Pressure
For people already managing hypertension, nicotine pouches pose specific concerns. The acute blood pressure spike from nicotine sits on top of an already elevated baseline, and the sympathetic activation can blunt the effectiveness of certain blood pressure medications. Beta-blockers, for instance, work by dampening sympathetic nervous system activity, which is exactly what nicotine ramps up. Using nicotine pouches while taking antihypertensives is essentially pressing the accelerator and brake at the same time.
The risk is amplified in people with existing cardiovascular disease. Nicotine’s ability to boost adrenaline heightens the hemodynamic load on the heart and vessels, and this can trigger acute cardiovascular events in people whose arteries are already narrowed or damaged.4Quality in Sport. The Effect of Different Nicotine Delivery Systems on Cardiovascular Health and Hemodynamic Load: A Literature Review If you have coronary artery disease, peripheral artery disease, or a history of stroke, any product that delivers nicotine deserves a conversation with your doctor, regardless of whether it is “tobacco-free.”
Sex Differences in Cardiovascular Response
Men and women respond to nicotine somewhat differently in terms of cardiovascular activation. Research examining the combination of nicotine exposure and stress found that men tended to have larger blood pressure increases, while women showed larger heart rate increases. In particular, the jump in systolic blood pressure and epinephrine from nicotine use to a subsequent stressor was significantly greater in men than in women.18PubMed Central. Sex Differences in Physiological Response to the Combination of Stress and Smoking This suggests that the hypertension risk from nicotine products may play out differently depending on sex, though both groups clearly experience cardiovascular effects. Most of the long-term snus studies were conducted in male populations, which means the evidence base for women’s long-term risk from oral nicotine is even thinner than it is for men.
The Menthol Question
Many nicotine pouches are menthol- or mint-flavored, and menthol is not just a passive flavoring. It has known vascular effects of its own. Menthol acts on ion channels in both the endothelium and vascular smooth muscle, and it can increase blood perfusion in skin by influencing nitric oxide and nerve-mediated vascular responses. There is growing evidence that several of menthol’s cellular targets are involved in cardiovascular diseases, including hypertension.19PubMed Central. Current Knowledge on the Vascular Effects of Menthol Whether the amount of menthol in a nicotine pouch is enough to meaningfully alter blood pressure on top of the nicotine effect is unknown. But the interaction is biologically plausible and adds another layer of uncertainty for people trying to assess the cardiovascular footprint of these products.
The broader issue is that nicotine pouches are regulated and studied as a category defined by what they lack (tobacco leaf, combustion) rather than by the full profile of what they contain. Flavoring agents, pH modifiers, humectants, and sweeteners all contact the oral mucosa, and the long-term vascular implications of that chemical cocktail are almost entirely unstudied. The nicotine itself is enough to raise real concerns about blood pressure, but the total formulation remains a black box.